JNJ Stock: Unusual Options Activity Signals Bullish Lean as Johnson & Johnson Trades Near 52-Week Highs
By TrendSpider Editor
Two unusual options contracts totaling $3,612,750 in combined premium have surfaced in Johnson & Johnson, drawing attention to the stock as it trades at $237.55, up 0.13% on the session. The activity includes a sizeable in-the-money call and a longer-dated out-of-the-money put, suggesting mixed but
JNJ Stock: Unusual Options Activity Signals Bullish Lean as Johnson & Johnson Trades Near 52-Week Highs
Two unusual options contracts totaling $3,612,750 in combined premium have surfaced in Johnson & Johnson, drawing attention to the stock as it trades at $237.55, up 0.13% on the session. The activity includes a sizeable in-the-money call and a longer-dated out-of-the-money put, suggesting mixed but broadly constructive positioning. With JNJ sitting close to its 52-week high of $251.705 and well above its 52-week low of $142.20, the options flow arrives at a technically significant moment for the stock.
Key Drivers of the JNJ Stock Move
- Main Catalyst: Two unusual options contracts were flagged today with a combined total premium of $3,612,750. A call at the $230 strike expiring July 17, 2026 printed with a size of 1,050 contracts and open interest utilization of 173%, while a put at the $210 strike expiring December 18, 2026 printed with a size of 1,500 contracts and open interest utilization of 113%.
- Bull Case: The $230 call is currently in the money with JNJ trading at $237.55, and its 173% open interest ratio indicates demand that is outpacing existing positioning. The $2,157,750 premium committed to that single contract reflects meaningful conviction on continued upside through mid-summer.
- Bear Case: The $210 put expiring December 18, 2026 represents a notable hedge against a potential pullback of more than 11% from current levels. At $1,455,000 in premium and 113% of open interest, it is not a trivial position, and its long-dated nature suggests at least some market participants are protecting against downside risk through the end of the year.
The forward setup for JNJ is shaped by the stock's proximity to its 52-week high of $251.705, leaving roughly 6% of runway before reaching that ceiling. The unusual call activity with a July expiration implies some options traders expect the stock to hold above $230 and potentially press higher over the next four months. At the same time, the December put serves as a reminder that the range from the 52-week low of $142.20 to the current price reflects a substantial recovery, and not all participants are confident that momentum will hold into late 2026. Johnson & Johnson's positioning across its pharmaceutical and MedTech segments will be a key factor in whether the stock can close the gap to its 52-week high or faces renewed pressure.
JNJ Unusual Options Activity
- Contract 1: Call | Strike: $230 | Expiry: July 17, 2026 | Volume: 1,050 | Open Interest: 173% of existing OI | Status: In the Money | Premium: $2,157,750
- Contract 2: Put | Strike: $210 | Expiry: December 18, 2026 | Volume: 1,500 | Open Interest: 113% of existing OI | Status: Out of the Money | Premium: $1,455,000
JNJ Seasonality
March has historically been part of a constructive seasonal window for large-cap healthcare names, as institutional rebalancing in the first quarter often benefits defensive sectors. The July expiration on the flagged call aligns with a period that has historically seen increased volatility around mid-year earnings cycles for JNJ.
JNJ Relative Performance
JNJ's current price of $237.55 represents a position near the upper half of its 52-week range spanning $142.20 to $251.705, indicating the stock has significantly outperformed its worst levels over the past year. Trading within roughly 6% of its 52-week high, JNJ is demonstrating relative strength compared to broad market conditions, positioning it as one of the more technically resilient names in the large-cap healthcare space heading into the second quarter of 2026.